SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Uppercut Brands, Inc. – ‘10-K’ for 12/31/19 – ‘EX-101.CAL’

On:  Friday, 3/20/20, at 5:08pm ET   ·   For:  12/31/19   ·   Accession #:  1213900-20-7000   ·   File #:  0-54872

Previous ‘10-K’:  ‘10-K’ on 4/4/19 for 12/31/18   ·   Next:  ‘10-K’ on 3/29/21 for 12/31/20   ·   Latest:  ‘10-K’ on 3/25/24 for 12/31/23   ·   12 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/20/20  Uppercut Brands, Inc.             10-K       12/31/19   73:18M                                    Edgar Agents LLC/FA

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    518K 
 2: EX-3.9      Certificate of Designation of the Series B          HTML     28K 
                Convertible Preferred Stock                                      
 3: EX-10.7     Form of Securities Purchase Agreement for the       HTML    245K 
                Purchase of Series B Preferred Shares, Dated                     
                November 2019, Between Uppercut Brands, Inc., and                
                Investors                                                        
 4: EX-10.8     Form of Warrant Related to Series B Preferred       HTML    108K 
                Shares, Dated November 2019, Between Uppercut                    
                Brands, Inc., and Investors                                      
 5: EX-10.9     Form of Registration Rights Agreement Related to    HTML    131K 
                Series B Preferred Shares, Dated November 2019,                  
                Between Uppercut Brands, Inc., and Investors                     
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     27K 
 7: EX-31.2     Certification -- §302 - SOA'02                      HTML     28K 
 8: EX-32.1     Certification -- §906 - SOA'02                      HTML     22K 
 9: EX-32.2     Certification -- §906 - SOA'02                      HTML     22K 
30: R1          Document and Entity Information                     HTML     60K 
67: R2          Balance Sheets                                      HTML     94K 
45: R3          Balance Sheets (Parenthetical)                      HTML     62K 
23: R4          Statements of Operations                            HTML     80K 
32: R5          Statements of Changes in Stockholders' Equity       HTML     79K 
                (Deficit)                                                        
69: R6          Statements of Cash Flows                            HTML    113K 
47: R7          Organization and Business                           HTML     29K 
26: R8          Summary of Significant Accounting Policies          HTML     63K 
29: R9          Acquisition                                         HTML     32K 
19: R10         Fair Value of Financial Instruments And Fair Value  HTML     47K 
                Measurements                                                     
41: R11         Inventory                                           HTML     26K 
60: R12         Notes Receivable                                    HTML     31K 
53: R13         Intangible Assets                                   HTML     28K 
18: R14         Convertible Notes Payable                           HTML     35K 
40: R15         Note Payable - Related Party                        HTML     24K 
59: R16         Stockholders? Equity (Deficit)                      HTML     66K 
52: R17         Income Taxes                                        HTML     42K 
20: R18         Concentrations                                      HTML     25K 
39: R19         Subsequent Events                                   HTML     24K 
73: R20         Summary of Significant Accounting Policies          HTML    118K 
                (Policies)                                                       
50: R21         Summary of Significant Accounting Policies          HTML     26K 
                (Tables)                                                         
28: R22         Acquisition (Tables)                                HTML     25K 
36: R23         Fair Value of Financial Instruments and Fair Value  HTML     45K 
                Measurements (Tables)                                            
72: R24         Inventory (Tables)                                  HTML     25K 
49: R25         Notes Receivable (Tables)                           HTML     26K 
27: R26         Intangible Assets (Tables)                          HTML     25K 
34: R27         Convertible Notes Payable (Tables)                  HTML     29K 
71: R28         Stockholders? Equity (Deficit) (Tables)             HTML     42K 
51: R29         Income Taxes (Tables)                               HTML     35K 
55: R30         Organization and Business (Details)                 HTML     25K 
61: R31         Summary of Significant Accounting Policies          HTML     30K 
                (Details)                                                        
37: R32         Summary of Significant Accounting Policies          HTML     47K 
                (Details Textual)                                                
16: R33         Acquisition (Details)                               HTML     31K 
56: R34         Acquisition (Details Textual)                       HTML     50K 
62: R35         Fair Value of Financial Instruments and Fair Value  HTML     27K 
                Measurements (Details)                                           
38: R36         Fair Value of Financial Instruments and Fair Value  HTML     30K 
                Measurements (Details 1)                                         
17: R37         Fair Value of Financial Instruments and Fair Value  HTML     26K 
                Measurements (Details 2)                                         
54: R38         Fair Value of Financial Instruments and Fair Value  HTML     27K 
                Measurements (Details 3)                                         
63: R39         Fair Value of Financial Instruments and Fair Value  HTML     23K 
                Measurements (Details Textual)                                   
44: R40         Inventory (Details)                                 HTML     28K 
66: R41         Notes Receivable (Details)                          HTML     29K 
31: R42         Notes Receivable (Details Textual)                  HTML     58K 
22: R43         Intangible Assets (Details)                         HTML     24K 
46: R44         Intangible Assets (Details Textual)                 HTML     35K 
68: R45         Convertible Notes Payable (Details)                 HTML     32K 
33: R46         Convertible Notes Payable (Details 1)               HTML     28K 
25: R47         Convertible Notes Payable (Details Textual)         HTML     53K 
43: R48         Note Payable - Related Party (Details)              HTML     33K 
70: R49         Stockholders? Equity (Deficit) (Details)            HTML     66K 
65: R50         Stockholders? Equity (Deficit) (Details Textual)    HTML    152K 
58: R51         Income Taxes (Details)                              HTML     39K 
21: R52         Income Taxes (Details 1)                            HTML     34K 
42: R53         Income Taxes (Details Textual)                      HTML     28K 
64: R54         Concentrations (Details)                            HTML     24K 
57: R55         Subsequent Events (Details)                         HTML     28K 
35: XML         IDEA XML File -- Filing Summary                      XML    124K 
48: EXCEL       IDEA Workbook of Financial Reports                  XLSX     74K 
10: EX-101.INS  XBRL Instance -- ucut-20191231                       XML    722K 
12: EX-101.CAL  XBRL Calculations -- ucut-20191231_cal               XML    134K 
13: EX-101.DEF  XBRL Definitions -- ucut-20191231_def                XML    432K 
14: EX-101.LAB  XBRL Labels -- ucut-20191231_lab                     XML    799K 
15: EX-101.PRE  XBRL Presentations -- ucut-20191231_pre              XML    639K 
11: EX-101.SCH  XBRL Schema -- ucut-20191231                         XSD    149K 
24: ZIP         XBRL Zipped Folder -- 0001213900-20-007000-xbrl      Zip    105K 


‘EX-101.CAL’   —   XBRL Calculations — ucut-20191231_cal


This Exhibit is an XBRL XML File.


                                                                                                                                                                                
<?xml version="1.0" standalone="no" encoding="windows-1252"?>
<!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 5.3a -->
<!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
<!-- Field: Doc-Info; Name: Source; Value: ucut_20191231.xfr; Date: 2020%2D03%2D20T16:18:30Z -->
<!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://pointcapitalinc.com/role/DocumentAndEntityInformation" xlink:href="ucut-20191231.xsd#DocumentAndEntityInformation" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/BalanceSheets" xlink:href="ucut-20191231.xsd#BalanceSheets" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/BalanceSheetsParenthetical" xlink:href="ucut-20191231.xsd#BalanceSheetsParenthetical" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/StatementsOfOperations" xlink:href="ucut-20191231.xsd#StatementsOfOperations" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/StatementsOfChangesInStockholdersEquityDeficit" xlink:href="ucut-20191231.xsd#StatementsOfChangesInStockholdersEquityDeficit" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/StatementsOfCashFlows" xlink:href="ucut-20191231.xsd#StatementsOfCashFlows" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/OrganizationAndBusiness" xlink:href="ucut-20191231.xsd#OrganizationAndBusiness" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="ucut-20191231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/Acquisition" xlink:href="ucut-20191231.xsd#Acquisition" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/FairValueOfFinancialInstrumentsAndFairValueMeasurements" xlink:href="ucut-20191231.xsd#FairValueOfFinancialInstrumentsAndFairValueMeasurements" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/Inventory" xlink:href="ucut-20191231.xsd#Inventory" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/NotesReceivable" xlink:href="ucut-20191231.xsd#NotesReceivable" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/IntangibleAssets" xlink:href="ucut-20191231.xsd#IntangibleAssets" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/ConvertibleNotesPayable" xlink:href="ucut-20191231.xsd#ConvertibleNotesPayable" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/NotePayable-RelatedParty" xlink:href="ucut-20191231.xsd#NotePayable-RelatedParty" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/StockholdersEquityDeficit" xlink:href="ucut-20191231.xsd#StockholdersEquityDeficit" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/IncomeTaxes" xlink:href="ucut-20191231.xsd#IncomeTaxes" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/Concentrations" xlink:href="ucut-20191231.xsd#Concentrations" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/SubsequentEvents" xlink:href="ucut-20191231.xsd#SubsequentEvents" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="ucut-20191231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="ucut-20191231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/AcquisitionTables" xlink:href="ucut-20191231.xsd#AcquisitionTables" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/FairValueOfFinancialInstrumentsAndFairValueMeasurementsTables" xlink:href="ucut-20191231.xsd#FairValueOfFinancialInstrumentsAndFairValueMeasurementsTables" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/InventoryTables" xlink:href="ucut-20191231.xsd#InventoryTables" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/NotesReceivableTables" xlink:href="ucut-20191231.xsd#NotesReceivableTables" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/IntangibleAssetsTables" xlink:href="ucut-20191231.xsd#IntangibleAssetsTables" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/ConvertibleNotesPayableTables" xlink:href="ucut-20191231.xsd#ConvertibleNotesPayableTables" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/StockholdersEquityDeficitTables" xlink:href="ucut-20191231.xsd#StockholdersEquityDeficitTables" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/IncomeTaxesTables" xlink:href="ucut-20191231.xsd#IncomeTaxesTables" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/OrganizationAndBusinessDetails" xlink:href="ucut-20191231.xsd#OrganizationAndBusinessDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:href="ucut-20191231.xsd#SummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsTextual" xlink:href="ucut-20191231.xsd#SummaryOfSignificantAccountingPoliciesDetailsTextual" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/AcquisitionDetails" xlink:href="ucut-20191231.xsd#AcquisitionDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/AcquisitionDetailsTextual" xlink:href="ucut-20191231.xsd#AcquisitionDetailsTextual" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/FairValueOfFinancialInstrumentsAndFairValueMeasurementsDetails" xlink:href="ucut-20191231.xsd#FairValueOfFinancialInstrumentsAndFairValueMeasurementsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/FairValueOfFinancialInstrumentsAndFairValueMeasurementsDetails1" xlink:href="ucut-20191231.xsd#FairValueOfFinancialInstrumentsAndFairValueMeasurementsDetails1" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/FairValueOfFinancialInstrumentsAndFairValueMeasurementsDetails2" xlink:href="ucut-20191231.xsd#FairValueOfFinancialInstrumentsAndFairValueMeasurementsDetails2" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/FairValueOfFinancialInstrumentsAndFairValueMeasurementsDetails3" xlink:href="ucut-20191231.xsd#FairValueOfFinancialInstrumentsAndFairValueMeasurementsDetails3" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/FairValueOfFinancialInstrumentsAndFairValueMeasurementsDetailsTextual" xlink:href="ucut-20191231.xsd#FairValueOfFinancialInstrumentsAndFairValueMeasurementsDetailsTextual" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/InventoryDetails" xlink:href="ucut-20191231.xsd#InventoryDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/NotesReceivableDetails" xlink:href="ucut-20191231.xsd#NotesReceivableDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/NotesReceivableDetailsTextual" xlink:href="ucut-20191231.xsd#NotesReceivableDetailsTextual" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/IntangibleAssetsDetails" xlink:href="ucut-20191231.xsd#IntangibleAssetsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/IntangibleAssetsDetailsTextual" xlink:href="ucut-20191231.xsd#IntangibleAssetsDetailsTextual" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/ConvertibleNotesPayableDetails" xlink:href="ucut-20191231.xsd#ConvertibleNotesPayableDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/ConvertibleNotesPayableDetails1" xlink:href="ucut-20191231.xsd#ConvertibleNotesPayableDetails1" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/ConvertibleNotesPayableDetailsTextual" xlink:href="ucut-20191231.xsd#ConvertibleNotesPayableDetailsTextual" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/NotePayable-RelatedPartyDetails" xlink:href="ucut-20191231.xsd#NotePayable-RelatedPartyDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/StockholdersEquityDeficitDetails" xlink:href="ucut-20191231.xsd#StockholdersEquityDeficitDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/StockholdersEquityDeficitDetailsTextual" xlink:href="ucut-20191231.xsd#StockholdersEquityDeficitDetailsTextual" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/IncomeTaxesDetails" xlink:href="ucut-20191231.xsd#IncomeTaxesDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/IncomeTaxesDetails1" xlink:href="ucut-20191231.xsd#IncomeTaxesDetails1" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/IncomeTaxesDetailsTextual" xlink:href="ucut-20191231.xsd#IncomeTaxesDetailsTextual" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/ConcentrationsDetails" xlink:href="ucut-20191231.xsd#ConcentrationsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://pointcapitalinc.com/role/SubsequentEventsDetails" xlink:href="ucut-20191231.xsd#SubsequentEventsDetails" xlink:type="simple"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/BalanceSheets" xlink:title="00000002 - Statement - Balance Sheets">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNi" xlink:label="loc_us-gaapEquitySecuritiesFvNi"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapEquitySecuritiesFvNi" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost" xlink:label="loc_us-gaapEquityMethodInvestmentAggregateCost"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapEquityMethodInvestmentAggregateCost" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet"/>
<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent" xlink:label="loc_us-gaapNotesAndLoansReceivableNetCurrent"/>
<link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapNotesAndLoansReceivableNetCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:label="loc_us-gaapNotesAndLoansReceivableNetNoncurrent"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapNotesAndLoansReceivableNetNoncurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="ucut-20191231.xsd#ucut_InsuranceFinanceLoanCurrent" xlink:label="loc_ucutInsuranceFinanceLoanCurrent"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_ucutInsuranceFinanceLoanCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaapConvertibleNotesPayableCurrent"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapConvertibleNotesPayableCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" weight="1"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Balance Sheets (Parenthetical)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Statements of Operations">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DevelopmentCosts" xlink:label="loc_us-gaapDevelopmentCosts"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapDevelopmentCosts" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralInsuranceExpense" xlink:label="loc_us-gaapGeneralInsuranceExpense"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralInsuranceExpense" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="ucut-20191231.xsd#ucut_BadDebtRecoveryExpense" xlink:label="loc_ucutBadDebtRecoveryExpense"/>
<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_ucutBadDebtRecoveryExpense" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense"/>
<link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaapAssetImpairmentCharges"/>
<link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapAssetImpairmentCharges" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInvestmentIncomeNet" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseRelatedParty" xlink:label="loc_us-gaapInterestExpenseRelatedParty"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpenseRelatedParty" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="ucut-20191231.xsd#ucut_RealizedGainLossOnEquityInvestments" xlink:label="loc_ucutRealizedGainLossOnEquityInvestments"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_ucutRealizedGainLossOnEquityInvestments" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="ucut-20191231.xsd#ucut_UnrealizedGainLossOnEquityInvestments" xlink:label="loc_ucutUnrealizedGainLossOnEquityInvestments"/>
<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_ucutUnrealizedGainLossOnEquityInvestments" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/StatementsOfChangesInStockholdersEquityDeficit" xlink:title="00000005 - Statement - Statements of Changes in Stockholders&apos; Equity (Deficit)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Statements of Cash Flows">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="ucut-20191231.xsd#ucut_AllocatedStockbasedCompensation" xlink:label="loc_ucutAllocatedStockbasedCompensation"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ucutAllocatedStockbasedCompensation" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses" xlink:label="loc_us-gaapRealizedInvestmentGainsLosses"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapRealizedInvestmentGainsLosses" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments" xlink:label="loc_us-gaapGainLossOnSaleOfInvestments"/>
<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainLossOnSaleOfInvestments" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories"/>
<link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther"/>
<link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
<link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentForAmortization" xlink:label="loc_us-gaapAdjustmentForAmortization"/>
<link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAdjustmentForAmortization" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaapAssetImpairmentCharges"/>
<link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAssetImpairmentCharges" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="loc_us-gaapOtherDepreciationAndAmortization"/>
<link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOtherDepreciationAndAmortization" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts"/>
<link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireNotesReceivable" xlink:label="loc_us-gaapPaymentsToAcquireNotesReceivable"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireNotesReceivable" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:label="loc_us-gaapPaymentsToAcquireEquityMethodInvestments"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireEquityMethodInvestments" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:label="loc_us-gaapProceedsFromSaleOfEquityMethodInvestments"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleOfEquityMethodInvestments" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/OrganizationAndBusiness" xlink:title="00000007 - Disclosure - Organization and Business"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - Summary of Significant Accounting Policies"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/Acquisition" xlink:title="00000009 - Disclosure - Acquisition"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/FairValueOfFinancialInstrumentsAndFairValueMeasurements" xlink:title="00000010 - Disclosure - Fair Value of Financial Instruments And Fair Value Measurements"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/Inventory" xlink:title="00000011 - Disclosure - Inventory"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/NotesReceivable" xlink:title="00000012 - Disclosure - Notes Receivable"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/IntangibleAssets" xlink:title="00000013 - Disclosure - Intangible Assets"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/ConvertibleNotesPayable" xlink:title="00000014 - Disclosure - Convertible Notes Payable"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/NotePayable-RelatedParty" xlink:title="00000015 - Disclosure - Note Payable - Related Party"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/StockholdersEquityDeficit" xlink:title="00000016 - Disclosure - Stockholders&#8217; Equity (Deficit)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/IncomeTaxes" xlink:title="00000017 - Disclosure - Income Taxes"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/Concentrations" xlink:title="00000018 - Disclosure - Concentrations"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/SubsequentEvents" xlink:title="00000019 - Disclosure - Subsequent Events"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000020 - Disclosure - Summary of Significant Accounting Policies (Policies)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000021 - Disclosure - Summary of Significant Accounting Policies (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/AcquisitionTables" xlink:title="00000022 - Disclosure - Acquisition (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/FairValueOfFinancialInstrumentsAndFairValueMeasurementsTables" xlink:title="00000023 - Disclosure - Fair Value of Financial Instruments and Fair Value Measurements (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/InventoryTables" xlink:title="00000024 - Disclosure - Inventory (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/NotesReceivableTables" xlink:title="00000025 - Disclosure - Notes Receivable (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/IntangibleAssetsTables" xlink:title="00000026 - Disclosure - Intangible Assets (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/ConvertibleNotesPayableTables" xlink:title="00000027 - Disclosure - Convertible Notes Payable (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/StockholdersEquityDeficitTables" xlink:title="00000028 - Disclosure - Stockholders&#8217; Equity (Deficit) (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/IncomeTaxesTables" xlink:title="00000029 - Disclosure - Income Taxes (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/OrganizationAndBusinessDetails" xlink:title="00000030 - Disclosure - Organization and Business (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:title="00000031 - Disclosure - Summary of Significant Accounting Policies (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsTextual" xlink:title="00000032 - Disclosure - Summary of Significant Accounting Policies (Details Textual)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/AcquisitionDetails" xlink:title="00000033 - Disclosure - Acquisition (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/AcquisitionDetailsTextual" xlink:title="00000034 - Disclosure - Acquisition (Details Textual)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/FairValueOfFinancialInstrumentsAndFairValueMeasurementsDetails" xlink:title="00000035 - Disclosure - Fair Value of Financial Instruments and Fair Value Measurements (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/FairValueOfFinancialInstrumentsAndFairValueMeasurementsDetails1" xlink:title="00000036 - Disclosure - Fair Value of Financial Instruments and Fair Value Measurements (Details 1)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/FairValueOfFinancialInstrumentsAndFairValueMeasurementsDetails2" xlink:title="00000037 - Disclosure - Fair Value of Financial Instruments and Fair Value Measurements (Details 2)">
<link:loc xlink:type="locator" xlink:href="ucut-20191231.xsd#ucut_EquityInvestmentsAtFairMarketValue" xlink:label="loc_ucutEquityInvestmentsAtFairMarketValue"/>
<link:loc xlink:type="locator" xlink:href="ucut-20191231.xsd#ucut_EquityInvestmentsAtOriginalCost" xlink:label="loc_ucutEquityInvestmentsAtOriginalCost"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ucutEquityInvestmentsAtFairMarketValue" xlink:to="loc_ucutEquityInvestmentsAtOriginalCost" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="ucut-20191231.xsd#ucut_GrossUnrealizedAppreciation" xlink:label="loc_ucutGrossUnrealizedAppreciation"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ucutEquityInvestmentsAtFairMarketValue" xlink:to="loc_ucutGrossUnrealizedAppreciation" xlink:type="arc" weight="1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/FairValueOfFinancialInstrumentsAndFairValueMeasurementsDetails3" xlink:title="00000038 - Disclosure - Fair Value of Financial Instruments and Fair Value Measurements (Details 3)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/FairValueOfFinancialInstrumentsAndFairValueMeasurementsDetailsTextual" xlink:title="00000039 - Disclosure - Fair Value of Financial Instruments and Fair Value Measurements (Details Textual)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/InventoryDetails" xlink:title="00000040 - Disclosure - Inventory (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/NotesReceivableDetails" xlink:title="00000041 - Disclosure - Notes Receivable (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesReceivableNet" xlink:label="loc_us-gaapNotesReceivableNet"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesReceivableGross" xlink:label="loc_us-gaapNotesReceivableGross"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNotesReceivableNet" xlink:to="loc_us-gaapNotesReceivableGross" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLosses" xlink:label="loc_us-gaapFinancingReceivableAllowanceForCreditLosses"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNotesReceivableNet" xlink:to="loc_us-gaapFinancingReceivableAllowanceForCreditLosses" xlink:type="arc" weight="-1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/NotesReceivableDetailsTextual" xlink:title="00000042 - Disclosure - Notes Receivable (Details Textual)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/IntangibleAssetsDetails" xlink:title="00000043 - Disclosure - Intangible Assets (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/IntangibleAssetsDetailsTextual" xlink:title="00000044 - Disclosure - Intangible Assets (Details Textual)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/ConvertibleNotesPayableDetails" xlink:title="00000045 - Disclosure - Convertible Notes Payable (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/ConvertibleNotesPayableDetails1" xlink:title="00000046 - Disclosure - Convertible Notes Payable (Details 1)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/ConvertibleNotesPayableDetailsTextual" xlink:title="00000047 - Disclosure - Convertible Notes Payable (Details Textual)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/NotePayable-RelatedPartyDetails" xlink:title="00000048 - Disclosure - Note Payable - Related Party (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/StockholdersEquityDeficitDetails" xlink:title="00000049 - Disclosure - Stockholders&#8217; Equity (Deficit) (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/StockholdersEquityDeficitDetailsTextual" xlink:title="00000050 - Disclosure - Stockholders&#8217; Equity (Deficit) (Details Textual)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/IncomeTaxesDetails" xlink:title="00000051 - Disclosure - Income Taxes (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/IncomeTaxesDetails1" xlink:title="00000052 - Disclosure - Income Taxes (Details 1)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/IncomeTaxesDetailsTextual" xlink:title="00000053 - Disclosure - Income Taxes (Details Textual)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/ConcentrationsDetails" xlink:title="00000054 - Disclosure - Concentrations (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://pointcapitalinc.com/role/SubsequentEventsDetails" xlink:title="00000055 - Disclosure - Subsequent Events (Details)"/>
</link:linkbase>


12 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/25/24  Silo Pharma, Inc.                 10-K       12/31/23   69:6.7M                                   EdgarAgents LLC/FA
 3/24/23  Silo Pharma, Inc.                 10-K       12/31/22   65:6.8M                                   EdgarAgents LLC/FA
 9/20/22  Silo Pharma, Inc.                 S-1/A                 78:9.4M                                   EdgarAgents LLC/FA
 9/09/22  Silo Pharma, Inc.                 S-1/A       9/08/22   80:9.6M                                   EdgarAgents LLC/FA
 8/29/22  Silo Pharma, Inc.                 S-1/A       8/26/22   79:9.5M                                   EdgarAgents LLC/FA
 7/25/22  Silo Pharma, Inc.                 S-1/A       7/22/22   78:9.9M                                   EdgarAgents LLC/FA
 3/28/22  Silo Pharma, Inc.                 10-K       12/31/21   69:6.2M                                   EdgarAgents LLC/FA
12/07/21  Silo Pharma, Inc.                 S-1        12/08/21   88:9.2M                                   EdgarAgents LLC/FA
 5/17/21  Silo Pharma, Inc.                 10-K/A     12/31/20   69:4.5M                                   EdgarAgents LLC/FA
 4/07/21  Silo Pharma, Inc.                 S-1/A                 65:4.4M                                   EdgarAgents LLC/FA
 3/29/21  Silo Pharma, Inc.                 10-K       12/31/20   69:4.5M                                   EdgarAgents LLC/FA
 2/16/21  Silo Pharma, Inc.                 S-1                   73:5.5M                                   EdgarAgents LLC/FA
Top
Filing Submission 0001213900-20-007000   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 6, 4:25:22.1am ET